PA
ATMU icon

PharVision Advisers’s Atmus Filtration Technologies ATMU Stock Holding History

PharVision Advisers’s Portfolio ATMU Stock Details ATMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,440
Closed -$331K – 284
2024
Q4 		$331K Buy
+8,440
New +$342K 0.28% 125

Other funds holding ATMU

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PharVision Advisers's ATMU Position: Q1 2025 in Review

PharVision Advisers sold out of Atmus Filtration Technologies (ATMU) in Q1 2025, closing a stake of 8,440 shares — an estimated $331K sold.

PharVision Advisers first reported a position in ATMU in Q4 2024 and held it in 1 quarter. The position peaked at $331K in Q4 2024. 276 funds tracked by Wall St. Rank hold ATMU as of Q1 2025.

  • PharVision Advisers reported no remaining Atmus Filtration Technologies position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 8,440 Atmus Filtration Technologies shares in Q1 2025, an estimated $331K.
  • PharVision Advisers first reported a position in Atmus Filtration Technologies in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's Atmus Filtration Technologies position peaked at $331K in Q4 2024.
  • 276 funds tracked by Wall St. Rank held Atmus Filtration Technologies as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.